| |
 |
|
Class Information
Number: 424/183.1
Name: Drug, bio-affecting and body treating compositions > Conjugate or complex of monoclonal or polyclonal antibody, immunoglobulin, or fragment thereof with nonimmunoglobulin material > Conjugated to proteinaceous toxin or fragment thereof (e.g., conjugated to diphtheria toxin, pseudomonas exotoxin, ricin, gelonin, abrin, etc.)
Description: Subject matter wherein the nonimmunoglobulin material is a proteinaceous toxin or fragment thereof.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 8703143 |
Antibodies of the ED-B domain of fibronectin, their construction and uses |
Apr. 22, 2014 |
| 8663642 |
Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders |
Mar. 4, 2014 |
| 8637012 |
Genetic products differentially expressed in tumors and the use thereof |
Jan. 28, 2014 |
| 8637027 |
Anti c-Met antibodies |
Jan. 28, 2014 |
| 8617556 |
Gram-positive bacteria specific binding compounds |
Dec. 31, 2013 |
| 8613903 |
Humanized L243 antibodies |
Dec. 24, 2013 |
| 8609105 |
Auristatin drug linker conjugates |
Dec. 17, 2013 |
| 8597655 |
Recombinant fusion protein and polynucleotide construct for immunotoxin production |
Dec. 3, 2013 |
| 8586047 |
Genetic products differentially expressed in tumors and the use thereof |
Nov. 19, 2013 |
| 8586714 |
Dual variable domain immunoglobulins and uses thereof |
Nov. 19, 2013 |
| 8562989 |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
Oct. 22, 2013 |
| 8545850 |
Anti-CD79B antibodies and immunoconjugates and methods of use |
Oct. 1, 2013 |
| 8540998 |
Methods for treating cancer using ephrin type-A receptor 10 antibodies conjugated to cytotoxic agents |
Sep. 24, 2013 |
| 8524241 |
Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A |
Sep. 3, 2013 |
| 8524240 |
Diagnosis and therapy of hematological malignancies |
Sep. 3, 2013 |
| 8524238 |
Cancer targets and uses thereof |
Sep. 3, 2013 |
| 8518409 |
System for selective cell treatment using ideotypically modulated pharmacoeffectors |
Aug. 27, 2013 |
| 8470330 |
PSMA antibodies and uses thereof |
Jun. 25, 2013 |
| 8460661 |
Methods of using antibodies that bind the glutamate ligand binding region of Notch1 |
Jun. 11, 2013 |
| 8444990 |
Antibody-induced apoptosis |
May. 21, 2013 |
| 8440195 |
Inhibition of CD69 for treatment of inflammatory conditions |
May. 14, 2013 |
| 8420094 |
Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A |
Apr. 16, 2013 |
| 8398982 |
Compositions and methods for the diagnosis and treatment of tumor |
Mar. 19, 2013 |
| 8394382 |
Siglec-9 Binding Agents |
Mar. 12, 2013 |
| 8388973 |
Compositions and methods for the treatment of tumor of hematopoietic origin |
Mar. 5, 2013 |
| 8383123 |
Method of treatment targeting HEPSIN |
Feb. 26, 2013 |
| 8383122 |
Process for preparing purified drug conjugates |
Feb. 26, 2013 |
| 8383117 |
CD44E tumor specific antibody |
Feb. 26, 2013 |
| 8367066 |
Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
Feb. 5, 2013 |
| 8333971 |
Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments |
Dec. 18, 2012 |
| 8329183 |
Recombinant fusion protein and polynucleotide construct for immunotoxin production |
Dec. 11, 2012 |
| 8278423 |
Monoclonal antibodies and fragment thereof directed against the human Anti-Mullerian Hormone type II receptor (AMHR-II) |
Oct. 2, 2012 |
| 8268309 |
Compositions and methods for the therapy and diagnosis of cytomegalovirus |
Sep. 18, 2012 |
| 8263041 |
Antigen associated with the neovasculature of tumour metastases |
Sep. 11, 2012 |
| 8263083 |
Combination therapy with antibody-drug conjugates |
Sep. 11, 2012 |
| 8263744 |
Binding proteins that bind to EpCAM linked to an effector molecule |
Sep. 11, 2012 |
| 8258268 |
Dual variable domain immunoglobulin and uses thereof |
Sep. 4, 2012 |
| 8257708 |
Antibodies against cancer antigen TMEFF2 and uses thereof |
Sep. 4, 2012 |
| 8226945 |
Antibodies and immunoconjugates and uses therefor |
Jul. 24, 2012 |
| 8216584 |
Imaging, diagnosis and treatment of disease |
Jul. 10, 2012 |
| 8211440 |
Multivalent immunoglobulin-based bioactive assemblies |
Jul. 3, 2012 |
| 8198416 |
Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
Jun. 12, 2012 |
| 8158128 |
Monoclonal antibodies to progastrin |
Apr. 17, 2012 |
| 8124094 |
Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same |
Feb. 28, 2012 |
| 8105596 |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
Jan. 31, 2012 |
| 8092809 |
Pseudomonas exotoxin A-like chimeric immunogens |
Jan. 10, 2012 |
| 8084029 |
Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
Dec. 27, 2011 |
| 8080250 |
Immunoconjugates with an intracellularly-cleavable linkage |
Dec. 20, 2011 |
| 8071093 |
Fully human anti-epidermal growth factor receptor antibodies |
Dec. 6, 2011 |
| 8071072 |
Cytotoxicity mediation of cells evidencing surface expression of CD44 |
Dec. 6, 2011 |
|
|
|
